Form DEF 14A Vicarious Surgical Inc. For: 17 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vicarious Surgical Inc. (RBOT)
Vicarious Surgical Inc. stock price live, this page displays OTC RBOT stock exchange data. View the RBOT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vicarious Surgical Inc. real time stock price chart below.
What Is the Vicarious Surgical Inc. Stock Price Today?
The Vicarious Surgical Inc. stock price today is 0.075.
What Is the Stock Symbol for Vicarious Surgical Inc.?
The stock symbol for Vicarious Surgical Inc. is "RBOT."
What Stock Exchange Does Vicarious Surgical Inc. Trade On?
Vicarious Surgical Inc. is listed and trades on the OTC Markets stock exchange.
Is Vicarious Surgical Inc. a Good Stock to Buy?
Determining whether Vicarious Surgical Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RBOT quote. (ISIN: US92561V2088)
What Is the Vicarious Surgical Inc. Stock Price Today?
The Vicarious Surgical Inc. stock price today is 0.075.
What Is the Stock Symbol for Vicarious Surgical Inc.?
The stock symbol for Vicarious Surgical Inc. is "RBOT."
What Stock Exchange Does Vicarious Surgical Inc. Trade On?
Vicarious Surgical Inc. is listed and trades on the OTC Markets stock exchange.
Is Vicarious Surgical Inc. a Good Stock to Buy?
Determining whether Vicarious Surgical Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RBOT quote. (ISIN: US92561V2088)
0.075
-0.010(-11.76%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.075
0.082
52 wk Range
0.073
10.500
RBOT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0750.082
52 wk Range
0.07310.500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RBOT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
5.000
Upside
+6,566.67%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Form PRE 14A Vicarious Surgical Inc. For: 17 June- Investing.com
Form DEF 14A Vicarious Surgical Inc. For: 23 March- Investing.com
Form 10Q VICARIOUS SURGICAL INC. For: 30 April- Investing.com
- Form DEF 14A Vicarious Surgical Inc. For: 17 July
- Investing.com
- Form PRE 14A Vicarious Surgical Inc. For: 17 June
- Investing.com
- Form 10Q VICARIOUS SURGICAL INC. For: 30 April
- Investing.com
Form 13D/A Vicarious Surgical Inc. For: 6 April- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 5.000
(+6,566.67% Upside)
Vicarious Surgical Inc. Earnings Call Summary for Q2/2025
- Operating expenses down 24% YoY to $13.5M; GAAP Net Loss improved to $13.2M or $2.23 per share
- Stock rose 12.5% to $9.2, later declined 1.63% in aftermarket; trading at $10.35 with 67% YoY return
- Clinical trials delayed to focus on system design; First Clinical Use target for 2025 removed
- Steven Fromm appointed as new CEO; projected 2025 cash burn of $50M
- $24M cash at quarter-end; company holds more cash than debt with 5.05 current ratio
Last Updated: 2025-08-12, 05:20 p/m
Read Full TranscriptEarnings
Latest Release
Apr 30, 2026
EPS / Forecast
-1.03 / -1.75
Revenue / Forecast
-- / --
Compare RBOT to Peers and Sector
Metrics to compare | RBOT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRBOTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −4.9x | −0.3x | |
PEG Ratio | 0.00 | 0.02 | 0.00 | |
Price/Book | 0.2x | 5.2x | 2.6x | |
Price / LTM Sales | - | 2.1x | 2.9x | |
Upside (Analyst Target) | - | 71.9% | 56.7% | |
Fair Value Upside | Unlock | 19.2% | 10.2% | Unlock |
Vicarious Surgical Inc. engages in the development and sale of single-port surgical robot in the United States. The company offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. Vicarious Surgical Inc. was founded in 2014 and is headquartered in Waltham, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Vicarious Surgical (RBOT) Stock Price Today?
The Vicarious Surgical stock price today is 0.075 USD.
What Stock Exchange Does Vicarious Surgical Trade On?
Vicarious Surgical is listed and trades on the OTC Markets.
What Is the Stock Symbol for Vicarious Surgical?
The stock symbol for Vicarious Surgical is "RBOT."
What Is the Vicarious Surgical Market Cap?
As of today, Vicarious Surgical market cap is 534.850K USD.
What Is Vicarious Surgical's Earnings Per Share (TTM)?
The Vicarious Surgical EPS (TTM) is -6.551.
When Is the Next Vicarious Surgical Earnings Date?
Vicarious Surgical will release its next earnings report on Aug 18, 2026.
From a Technical Analysis Perspective, Is RBOT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Vicarious Surgical Stock Split?
Vicarious Surgical has split 1 times.
How Many Employees Does Vicarious Surgical Have?
Vicarious Surgical has 48 employees.
What is the current trading status of Vicarious Surgical (RBOT)?
As of Jul 30, 2026, Vicarious Surgical (RBOT) is trading at a price of 0.075 USD, with a previous close of 0.085 USD. The stock has fluctuated within a day range of 0.075 USD to 0.082 USD, while its 52-week range spans from 0.073 USD to 10.500 USD.
What Is Vicarious Surgical (RBOT) Price Target According to Analysts?
The average 12-month price target for Vicarious Surgical is 5.000 USD, with a high estimate of 5 USD and a low estimate of 5 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +6,566.67% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.